TI-0032-III Injection

· Therorna

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TI-0032-III Injection, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases [Phase 1]